Investigations	28 (12.1)
Aspartate aminotransferase increased	12 (5.2)
Alanine aminotransferase increased	10 (4.3)
Platelet count decreased	8 (3.4)
Gamma-glutamyltransferase increased	7 (3.0)
Bilirubin conjugated increased	3 (1.3)
Blood bilirubin increased	3 (1.3)
Neutrophil count decreased	3 (1.3)
White blood cell count decreased	2 (0.9)
Blood bilirubin unconjugated increased	1 (0.4)
Blood creatinine increased	1 (0.4)
Blood thyroid stimulating hormone increased	1 (0.4)
Thyroxine free decreased	1 (0.4)
Tri-iodothyronine decreased	1 (0.4)
Tri-iodothyronine free decreased	1 (0.4)
Gastrointestinal disorders	10 (4.3)
Abdominal pain	3 (1.3)
Diarrhoea	3 (1.3)
Enteritis	1 (0.4)
Gingival bleeding	1 (0.4)
Haematochezia	1 (0.4)
Large intestine perforation	1 (0.4)
Mouth ulceration	1 (0.4)
Nausea	1 (0.4)
Vomiting	1 (0.4)
Endocrine disorders	6 (2.6)
Hypothyroidism	2 (0.9)
Thyroiditis	2 (0.9)
Autoimmune thyroiditis	1 (0.4)
Hyperthyroidism	1 (0.4)
Metabolism and nutrition disorders	5 (2.2)
Decreased appetite	2 (0.9)
Hyperglycaemia	1 (0.4)
Hyperkalaemia	1 (0.4)
Hyperlipidaemia	1 (0.4)
Skin and subcutaneous tissue disorders	5 (2.2)
Rash	2 (0.9)
Dermatitis acneiform	1 (0.4)
Dermatitis bullous	1 (0.4)
Drug eruption	1 (0.4)
Immune-mediated dermatitis	1 (0.4)
General disorders and administration site conditions	4 (1.7)
Asthenia	2 (0.9)
Pyrexia	2 (0.9)
Oedema peripheral	1 (0.4)
Infections and infestations	4 (1.7)
Conjunctivitis	1 (0.4)
Gingivitis	1 (0.4)
Pelvic inflammatory disease	1 (0.4)
Pneumonia bacterial	1 (0.4)
Staphylococcal infection	1 (0.4)
Renal and urinary disorders	4 (1.7)
Proteinuria	3 (1.3)
Haematuria	1 (0.4)
Renal impairment	1 (0.4)
Cardiac disorders	3 (1.3)
Cardiac failure	1 (0.4)
Myocardial ischaemia	1 (0.4)
Sinus tachycardia	1 (0.4)
Hepatobiliary disorders	3 (1.3)
Hepatic function abnormal	2 (0.9)
Immune-mediated hepatitis	1 (0.4)
Jaundice	1 (0.4)
Respiratory, thoracic and mediastinal disorders	3 (1.3)
Pneumonitis	2 (0.9)
Bronchial haemorrhage	1 (0.4)
Blood and lymphatic system disorders	2 (0.9)
Anaemia	1 (0.4)
Myelosuppression	1 (0.4)
Nervous system disorders	2 (0.9)
Cognitive disorder	1 (0.4)
Headache	1 (0.4)
Vascular disorders	2 (0.9)
Hypertension	2 (0.9)
Reproductive system and breast disorders	1 (0.4)
Female genital tract fistula	1 (0.4)
